<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><?origin capmc?><?iso-abbr Genes Immun.?><?submitter-system camss?><?submitter-canonical-name Nature Publishing Group?><?submitter-canonical-id NATURE-STRUCTUR?><?submitter-userid 3198?><?submitter-authority CAPMC?><?submitter-login nature?><?submitter-name Nature Publishing?><?domain capmc?><?ppubseason Jul-Aug?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">100953417</journal-id><journal-id journal-id-type="pubmed-jr-id">21482</journal-id><journal-id journal-id-type="nlm-ta">Genes Immun</journal-id><journal-id journal-id-type="iso-abbrev">Genes Immun.</journal-id><journal-title-group><journal-title>Genes and immunity</journal-title></journal-title-group><issn pub-type="ppub">1466-4879</issn><issn pub-type="epub">1476-5470</issn></journal-meta><article-meta><article-id pub-id-type="pmcid">4111656</article-id><article-id pub-id-type="pmid">24807690</article-id><article-id pub-id-type="doi">10.1038/gene.2014.17</article-id><article-id pub-id-type="manuscript">capmc4329</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Contribution of increased ISG15, ISGylation and deregulated Type I IFN signaling in <italic>Usp18</italic> mutant mice during the course of bacterial infections</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dauphinee</surname><given-names>Shauna M.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Richer</surname><given-names>Etienne</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Eva</surname><given-names>Megan M.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>McIntosh</surname><given-names>Fiona</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Paquet</surname><given-names>Maril&#x000e8;ne</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Dangoor</surname><given-names>David</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Burkart</surname><given-names>Christoph</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Dong-Er</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Gruenheid</surname><given-names>Samantha</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Gros</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Behr</surname><given-names>Marcel</given-names></name><xref ref-type="aff" rid="A10">10</xref></contrib><contrib contrib-type="author"><name><surname>Malo</surname><given-names>Danielle</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A10">10</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Department of Human Genetics, McGill University, Montreal, QC, Canada</aff><aff id="A2">
<label>2</label>Complex Traits Group, McGill University, Montreal, QC, Canada</aff><aff id="A3">
<label>3</label>Department of Biology, McGill University, Montreal, QC, Canada</aff><aff id="A4">
<label>4</label>Montreal General Hospital, McGill University, Montreal, Quebec, Canada</aff><aff id="A5">
<label>5</label>D&#x000e9;partement de pathologie et de microbiologie, Facult&#x000e9; de M&#x000e9;decine V&#x000e9;t&#x000e9;rinaire, Universit&#x000e9; de Montr&#x000e9;al, Saint-Hyacinthe, Qu&#x000e9;bec</aff><aff id="A6">
<label>6</label>Moores Cancer Center, University of California San Diego, La Jolla, CA, USA</aff><aff id="A7">
<label>7</label>Department of Pathology, University of California San Diego, La Jolla, CA, USA</aff><aff id="A8">
<label>8</label>Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada</aff><aff id="A9">
<label>9</label>Department of Biochemistry, McGill University, Montreal, QC, Canada</aff><aff id="A10">
<label>10</label>Department of Medicine, McGill University, Montreal, QC, Canada</aff><author-notes><corresp id="FN1">Corresponding author: Danielle Malo, McGill University, 3649 Sir William Osler Promenade, Montreal, QC, H3G 0B1, Canada, <email>danielle.malo@mcgill.ca</email>, Tel: 514-398-3907, Fax: 514-398-2603</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>8</day><month>4</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>08</day><month>5</month><year>2014</year></pub-date><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>1</month><year>2015</year></pub-date><volume>15</volume><issue>5</issue><fpage>282</fpage><lpage>292</lpage><!--elocation-id from pubmed: 10.1038/gene.2014.17--><permissions><license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms"><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p></license></permissions><abstract><p id="P1">Host genetics plays a key role in susceptibility to S<italic>almonella</italic> Typhimurium infection. We previously used <italic>N</italic>-ethyl-<italic>N</italic>-nitrosourea (ENU) mutagenesis to identify a loss of function mutation within the gene ubiquitin specific peptidase 18 (<italic>Usp18<sup>Ity9</sup></italic>), which confers increased susceptibility to <italic>Salmonella</italic> Typhimurium. USP18 functions to regulate type I IFN signaling and as a protease to remove ISG15 from substrate proteins. <italic>Usp18<sup>Ity9</sup></italic> mice are susceptible to infection with <italic>Salmonella</italic> Typhimurium and have increased expression and function of ISG15, but <italic>Usp18<sup>Ity9</sup></italic> mice lacking <italic>Isg15</italic> do not show improved survival with <italic>Salmonella</italic> challenge. Type I IFN signaling is increased in <italic>Usp18<sup>Ity9</sup></italic> mice and inhibition of type I IFN signaling is associated with improved survival in mutant mice. Hyperactivation of type I IFN signaling leads to increased IL-10, deregulated expression of autophagy markers, and elevated IL-1&#x003b2; and IL-17. Furthermore, <italic>Usp18<sup>Ity9</sup></italic> mice are more susceptible to infection with <italic>Mycobacterium tuberculosis</italic>, have increased bacterial load in lung and spleen, elevated inflammatory cytokines and more severe lung pathology. These findings demonstrate that regulation of type I IFN signaling is the predominant mechanism affecting the susceptibility of <italic>Usp18<sup>Ity9</sup></italic> mice to <italic>Salmonella</italic> infection and that hyperactivation of signaling leads to increased IL-10, deregulation of autophagic markers and increased proinflammatory cytokine production.</p></abstract><kwd-group><kwd>USP18</kwd><kwd>innate immunity</kwd><kwd>Salmonella</kwd><kwd>mycobacteria</kwd><kwd>type I IFN</kwd><kwd>ISGylation</kwd><kwd>autophagy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>INTRODUCTION</title><p id="P2"><italic>Salmonella enterica</italic> are facultative, intracellular, gram-negative enterobacteria that cause a range of enteric diseases in mammalian hosts. The human restricted serovars <italic>Salmonella enterica</italic> Typhi and Paratyphi are the causal agents of Typhoid fever, affecting more than 27 million people worldwide and resulting in greater than 200 000 deaths each year through contaminated food and drinking water (<xref rid="R1" ref-type="bibr">1</xref>). In contrast, infection with the <italic>Salmonella enterica</italic> serovar Typhimurium results in a self-limiting gastroenteritis in humans, but in mice, is an established model of fatal systemic disease, whereby infection leads to dissemination of the bacteria to the spleen and liver and activation of both innate and adaptive immune responses. Typhoid fever remains an important global health issue due to geographic spread as a result of foreign travel to areas of endemicity, including Africa and Asia.</p><p id="P3">The outcome and severity of infection with <italic>Salmonella</italic> is dependent on several parameters including microbial virulence factors, environment, immune status and host genetics. Numerous quantitative trait loci influencing microbial pathogenicity have been discovered from the inherent differential susceptibility of inbred mouse strains (<xref rid="R2" ref-type="bibr">2</xref>). However, to identify additional gene candidates important during <italic>Salmonella</italic> infection, we have used a large-scale <italic>N</italic>-ethyl-<italic>N</italic>-nitrosurea (ENU) mutagenesis screen. Our ENU screen has previously identified a loss of function mutation within the gene ubiquitin specific peptidase 18 (<italic>Usp18<sup>Ity9</sup></italic>), which confers increased susceptibility to <italic>Salmonella</italic> Typhimurium (<xref rid="R3" ref-type="bibr">3</xref>). We have previously shown that the decreased survival in mice that carry a point mutation in <italic>Usp18</italic> results from increased bacterial load in the spleen and liver, an increased inflammatory response and increased type I IFN signaling through STAT1 activation (<xref rid="R3" ref-type="bibr">3</xref>). USP18 functions both to regulate the type I IFN signaling pathway, and independently, as a protease to remove ISG15 adducts from substrate proteins (<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R5" ref-type="bibr">5</xref>). However, the contribution of hyperactivation of type I IFN signaling and the host ISGylation pathway to the susceptibility of <italic>Usp18<sup>Ity9</sup></italic> mice has not been fully characterized.</p><p id="P4">Although the role of type I IFN in the host response to viral infection is well established, its role during bacterial infection is more controversial with activities that are both favorable and detrimental for the host (reviewed in (<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>)). In addition to providing a protective role during infection, the production of type I IFN is also associated with suppression of the innate immune response through mechanisms that include decreasing the antibacterial production or function of IFN-&#x003b3; (<xref rid="R8" ref-type="bibr">8</xref>), promoting the generation of IL-10-producing regulatory T cells (<xref rid="R9" ref-type="bibr">9</xref>) and decreasing the recruitment of leukocytes to the site of infection (<xref rid="R10" ref-type="bibr">10</xref>). Thus, an increase in type I IFN signaling can lead to increased susceptibility of the host to bacterial infection (<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R11" ref-type="bibr">11</xref>).</p><p id="P5">Autophagy, a cellular degradation pathway, has emerged as a key component of the innate immune system through recognition and elimination of intracellular bacteria (reviewed in (<xref rid="R12" ref-type="bibr">12</xref>)). Upon entry into the cell, <italic>Salmonella</italic> reside within specialized vesicles called <italic>Salmonella</italic> containing vacuoles (SCV). Damage to the SCV membrane results in escape of the <italic>Salmonella</italic> to the cytosol and accumulation of polyubiquitinated proteins on the surface of the bacteria (<xref rid="R13" ref-type="bibr">13</xref>). Autophagy has been shown to limit the growth of <italic>Salmonella</italic> Typhimurium through association between ubiquitinated proteins and autophagic cargo receptors, including p62 (SQSTM1), NDP52 and optineurin (OPTN) (<xref rid="R14" ref-type="bibr">14</xref>&#x02013;<xref rid="R17" ref-type="bibr">17</xref>). Recognition of the bacteria by these receptors facilitates interaction with the autophagy-related gene 8/microtubule-associated protein 1 light chain 3 (ATG8/LC3) family of proteins at the phagophore, resulting in lysosomal fusion and degradation of the bacteria. Autophagy is regulated by both host and pathogen-derived immune signals. Several cytokines have been reported to play an important role in either upregulating (IFN&#x003b3;, TNF&#x003b1;, IL-1&#x003b2;) or inhibiting (IL-4, IL13, IL-10) autophagy (<xref rid="R18" ref-type="bibr">18</xref>). However, deregulation of autophagy as a consequence of increased cytokine production during <italic>Salmonella</italic> infection has not been described.</p><p id="P6">Given that USP18 suppresses type I IFN signaling and that the mutation in <italic>Usp18<sup>Ity9</sup></italic> mice lies within the IFNAR2-binding region of USP18 (<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>), as well as the importance of type I IFN signaling in bacterial infection, we sought to determine if the IFNAR regulatory function of USP18 is compromised in <italic>Usp18<sup>Ity9</sup></italic> mice and whether hyperactivation of type I IFN signaling contributes to the pathogenesis of infection. In this study, we show that <italic>Usp18<sup>Ity9</sup></italic> mice succumb to <italic>Salmonella</italic> infection due to an inability to regulate type I IFN signaling, which in turn results in increased IL-10 production and deregulation of autophagy cargo receptors. Furthermore, this influences the production of IL-1&#x003b2; and the amount of IL-17 produced from CD4+ T cells. These data demonstrate for the first time a link between type I IFN and autophagy in <italic>Salmonella</italic> infected mice.</p></sec><sec sec-type="results" id="S2"><title>RESULTS</title><sec id="S3" sec-type="background"><title>The genetic background significantly affects the expressivity of the Usp18<sup>Ity9</sup> mutation</title><p id="P7">USP18 has two known functions including the deconjugation of the ubiquitin-like modifier protein ISG15 from target proteins and the inhibition of type I IFN-induced JAK/STAT activation (<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R19" ref-type="bibr">19</xref>). To address the relative importance of these two functions in <italic>Usp18<sup>Ity9</sup></italic> mice, we first transferred the <italic>Usp18<sup>Ity9</sup></italic> allele from the mixed genetic background of C57BL/6 &#x000d7; 129S1 &#x000d7; DBA/2J (<xref rid="R3" ref-type="bibr">3</xref>) to homogenous 129S1, DBA/2J or C57BL/6J inbred strains. This was particularly important to minimize the confounding effects of the mixed background on the expression of the <italic>Usp18<sup>Ity9</sup></italic> phenotype during infection and to have the mutation on the appropriate background for further evaluation of susceptibility to other important human pathogens. The genetic background significantly affected viability. <italic>Usp18<sup>Ity9</sup></italic> mutant mice were found in the expected frequencies in 129S1 and DBA/2J, whereas homozygous animals showed perinatal lethality in the C57BL/6J genetic background (data not shown). These findings are consistent with perinatal lethality observed in the C57BL/6J background for <italic>Usp18<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref rid="R20" ref-type="bibr">20</xref>).</p><p id="P8">The transfer of the <italic>Usp18<sup>Ity9</sup></italic> mutation to 129S1 or DBA/2J background resulted in decreased survival to <italic>Salmonella</italic> Typhimurium infection although the susceptibility was delayed in the 129S1 background compared to mice on a DBA/2J or a mixed genetic background (<xref rid="F1" ref-type="fig">Fig. 1A</xref>, left and right panel respectively, and (<xref rid="R3" ref-type="bibr">3</xref>)). Consistent with our earlier findings in original mixed-strain background mice, 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> and D2.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice had significantly increased bacterial load in the spleen and liver post-infection compared with wild-type mice (<xref rid="F1" ref-type="fig">Fig. 1B</xref>, left and right panel respectively ). In addition, 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> and D2.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice had elevated levels of serum IL-6 (<xref rid="F1" ref-type="fig">Fig. 1C</xref>, left and right panel respectively), indicative of a systemic pro-inflammatory response. However, in contrast to <italic>Usp18<sup>Ity9</sup></italic> mice on a mixed background, which showed a transient decrease in IFN-&#x003b3; production following <italic>Salmonella</italic> infection, serum IFN-&#x003b3; levels were not significantly different in 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> and D2.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice compared to wild-type controls (<xref rid="F1" ref-type="fig">Fig. 1D</xref>, left and right panel respectively). Moreover, the transient decrease in IFN-&#x003b3; production observed in mixed background mutant mice was not seen at days 1 and 5 post-infection in 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice compared to control (data not shown).</p><p id="P9">Taken together, these results demonstrate that the increased susceptibility of <italic>Ity9</italic> mutant mice is 100% penetrant when the mutation is transferred to a homogenous 129S1 or DBA/2J genetic background, albeit with variable expressivity that could be explained by the inherent degree of susceptibility of the background strains, the DBA/2J presenting an intermediate phenotype and the 129S1 being highly resistant to infection (<xref rid="R21" ref-type="bibr">21</xref>). The susceptibility is paralleled by an increase in bacterial load at systemic sites of infection and an increase in pro-inflammatory cytokines, collectively contributing to the clinical phenotype. The difference in the IFN-&#x003b3; response in the 129S1 and DBA/2J congenic mice suggests that strain-specific modifier genes, most likely contributed from the C57BL/6J background, may be involved in the regulation of IFN-&#x003b3; levels in <italic>Usp18<sup>Ity9</sup></italic> mice.</p></sec><sec id="S4" sec-type="discussion"><title>Loss of ISG15 had no impact on early susceptibility of Usp18<sup>Ity9</sup> mice to <italic>Salmonella</italic> infection although it mediated delayed susceptibility in wild-type mice</title><p id="P10">To determine the contribution of ISG15 to the <italic>Usp18<sup>Ity9</sup></italic> phenotype, we examined ISG15 expression and function <italic>in vivo</italic> and <italic>in vitro</italic>. 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic>mice have increased spleen <italic>Isg15</italic> mRNA expression both prior to infection and following <italic>Salmonella</italic> challenge (<xref rid="F2" ref-type="fig">Fig. 2A</xref>) and circulating ISG15 post-infection (<xref rid="F2" ref-type="fig">Fig. 2B</xref>). Such increased expression is likely due to the enhanced type I IFN signaling in <italic>Usp18<sup>Ity9</sup></italic> mice since <italic>ISG15</italic> is a well-known IFN-inducible gene. To determine whether the increase in <italic>Isg15</italic> mRNA expression correlated to an increase in ISG15 conjugation to other proteins, we isolated BMDM from 129S1 wild-type and 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> mutant mice and examined protein ISGylation. We found that ISG15-conjugation was significantly increased in mutant cells, under basal conditions and in cells stimulated with LPS (<xref rid="F2" ref-type="fig">Fig. 2C</xref>) compared to wild-type BMDM, suggesting that the loss of functional USP18 in <italic>Usp18<sup>Ity9</sup></italic> mutant mice contributes to a decrease in deISGylation. To determine if the <italic>Usp18<sup>Ity9</sup></italic> mutation affected the enzymatic function of human USP18, we have used USP18 mutant constructed with the corresponding mutation in the human sequence (L365F) to transfect HEK293T cells. The levels of USP18 protein expression were similar in wild-type and USP18<sup>L365F</sup> transfected cells. As observed in <italic>Ity9</italic> mutant mice, there was a reduction in deISGylation in HEK293T cells transfected with USP18<sup>L365F</sup> compared to wild-type USP18. Levels of ISGylation in USP18<sup>L365F</sup> transfected cells were comparable to those detected in the absence of USP18 (<xref rid="F2" ref-type="fig">Fig. 2D</xref>).</p><p id="P11">To examine the impact of increased ISG15 and ISGylation <italic>in vivo</italic>, we generated <italic>Usp18/Isg15</italic> double-deficient mice by intercrossing <italic>Usp18<sup>Ity9</sup></italic> mice and <italic>Isg15</italic> knockout mice. We showed that the <italic>Isg15</italic> genotypes (+/+, +/&#x02212; or &#x02212;/&#x02212;) had no impact on survival to infection in <italic>Usp18<sup>Ity9</sup></italic> mice (<xref rid="F2" ref-type="fig">Fig. 2E</xref>). Correspondingly, there was no difference in spleen and liver bacterial load 4 days post-infection between <italic>Usp18<sup>Ity9</sup>Isg15<sup>+/+</sup></italic> and <italic>Usp18<sup>Ity9</sup>Isg15<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref rid="F2" ref-type="fig">Fig. 2F</xref>). Interestingly, <italic>Usp18<sup>+/+</sup></italic> mice lacking <italic>Isg15</italic> showed a slight decrease in survival later during infection (<xref rid="F2" ref-type="fig">Fig. 2E</xref>) and this was paralleled by an increase in bacterial load of 2.6-fold in the spleen and 4.5-fold in the liver at 8 days post-infection (<xref rid="F2" ref-type="fig">Fig 2G</xref>). These results demonstrate that increased <italic>Isg15</italic> and ISGylation are not primarily responsible for the susceptibility phenotype observed in <italic>Usp18<sup>Ity9</sup></italic> mice, although loss of <italic>Isg15</italic> does mediate susceptibility and increased bacterial load later during S<italic>almonella</italic> infection in wild-type <italic>Usp18</italic> mice.</p></sec><sec id="S5"><title>Blocking type I IFN receptor signaling improves survival of Usp18<sup>Ity9</sup> mice to infection with <italic>Salmonella</italic></title><p id="P12">Independent of its isopeptidase activity, USP18 is a negative regulator of type I IFN signaling through binding to the IFNAR2 receptor and blocking interaction between JAK and the type I IFN receptor (<xref rid="R4" ref-type="bibr">4</xref>). The mutation in <italic>Usp18<sup>Ity9</sup></italic> mice lies within the IFNAR2-binding region of USP18 suggesting that it may interfere with its regulatory function. We have previously shown that <italic>Usp18<sup>Ity9</sup></italic> mice on a mixed background have increased levels of <italic>Ifnb</italic> transcript and increased STAT1 phosphorylation downstream of the receptor (<xref rid="R3" ref-type="bibr">3</xref>). Similarly, 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice showed increased basal <italic>Ifnb</italic> mRNA expression (<xref rid="F3" ref-type="fig">Fig. 3A</xref>) and increased STAT1 activation following <italic>Salmonella</italic> infection (<xref rid="F3" ref-type="fig">Fig. 3B</xref>). Increased STAT1 activation was also observed in HeLa cells transfected with human USP18<sup>L365F</sup> following stimulation with IFN&#x003b1; (<xref rid="F3" ref-type="fig">Fig. 3C</xref>). Together, these results indicate that in addition to enzyme inactivation, this single amino acid mutation of USP18 leads to loss of the inhibitory function of USP18 in type I IFN signaling.</p><p id="P13">To determine the impact of type I IFN signaling on the survival of 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice, we treated mice with the IFN&#x003b1;/&#x003b2; receptor 1 (IFNAR1)-specific MAR1-5A3 monoclonal antibody one day prior to infection with <italic>S.</italic> Typhimurium. This antibody has been shown to potently inhibit type I IFN receptor signaling in mouse models of infection (<xref rid="R22" ref-type="bibr">22</xref>). <italic>Usp18<sup>Ity9</sup></italic> mice that were pretreated with the MAR1-5A3 antibody showed improved survival following <italic>Salmonella</italic> infection compared to mice that received an isotype control (<xref rid="F3" ref-type="fig">Fig. 3D</xref>). The MAR1-5A3 treated mice also had significantly reduced bacterial loads in the spleen and liver (<xref rid="F3" ref-type="fig">Fig. 3E</xref>). Taken together, these results suggest that loss of the regulation of the type I IFN signaling pathway that is normally imparted by USP18 contributes to the increase in susceptibility of mutant mice to <italic>Salmonella</italic> infection.</p></sec><sec id="S6"><title>Usp18<sup>Ity9</sup> mice have increased IL-10 and deregulation of the levels of autophagy substrates</title><p id="P14">Given that type I IFN has been shown to induce IL-10 in a STAT1-dependent manner, (<xref rid="R23" ref-type="bibr">23</xref>), we examined whether the increase in type I IFN signaling in <italic>Usp18<sup>Ity9</sup></italic> mice affected IL-10 production. At 8 days post-infection, 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice had elevated <italic>Il10</italic> transcript in the spleen (<xref rid="F4" ref-type="fig">Fig. 4A</xref>) and an increase in circulating IL-10 (<xref rid="F4" ref-type="fig">Fig. 4B</xref>). Consistent with the finding that STAT3 is activated downstream of the IL-10 receptor (<xref rid="R24" ref-type="bibr">24</xref>), we also observed that infected <italic>Usp18<sup>Ity9</sup></italic> mice had elevated levels of phosphorylated STAT3 in the spleen (<xref rid="F4" ref-type="fig">Fig. 4C</xref>).</p><p id="P15">Several studies have demonstrated a role for autophagy in innate immunity to <italic>Salmonella</italic> infection (<xref rid="R14" ref-type="bibr">14</xref>, <xref rid="R15" ref-type="bibr">15</xref>). Since IL-10 is an inhibitor of autophagy (<xref rid="R25" ref-type="bibr">25</xref>), we next asked whether the increase in IL-10 in <italic>Usp18<sup>Ity9</sup></italic> mice affected the expression of autophagy markers <italic>in vivo</italic>. We collected lysates from spleen tissues of <italic>Usp18<sup>Ity9</sup></italic>mice and wild-type controls and assessed the levels of the autophagy cargo receptor, p62 (SQSTM1), which has been shown to accumulate <italic>in vivo</italic> in conditions where autophagy is repressed (<xref rid="R26" ref-type="bibr">26</xref>). Indeed, <italic>Usp18<sup>Ity9</sup></italic>mice showed increased accumulation of p62 following infection compared to wild-type controls (<xref rid="F4" ref-type="fig">Fig. 4D</xref>), and this was not a consequence of increased p62 transcript (<xref rid="F4" ref-type="fig">Fig. 4G</xref>). To further study the impact of <italic>Usp18<sup>Ity9</sup></italic> on autophagic markers, we measured LC3 conversion in the spleen of wild-type and mutant mice during infection. LC3 is a ubiquitin-like protein that undergoes phosphatidylethanolamine modification to facilitate association with <italic>Salmonella</italic> during infection (<xref rid="R27" ref-type="bibr">27</xref>). The conversion of LC3 (LC3I) to its lipidated form (LC3II) is correlated with the formation of autophagosomes. We found that the intensity of the LC3I and LC3II bands was decreased relative to &#x003b2;-actin in the <italic>Usp18<sup>Ity9</sup></italic> mice in comparison to wild-type mice before and during <italic>Salmonella</italic> infection, although to a greater extent following bacterial infection (<xref rid="F4" ref-type="fig">Fig. 4E</xref>). During <italic>Salmonella</italic> infection, an additional autophagy receptor, optineurin (OPTN), is recruited to ubiquitylated bacteria in the cytosol and, following phosphorylation by TBK1, binds LC3 to bring <italic>Salmonella</italic> to the autophagosome (<xref rid="R16" ref-type="bibr">16</xref>). Therefore, we assessed the levels of OPTN in <italic>Usp18<sup>Ity9</sup></italic> mice to further define the impact of the mutation on autophagy during <italic>Salmonella</italic> infection. We found that <italic>Usp18<sup>Ity9</sup></italic> mice had decreased levels of <italic>Optn</italic> transcript and OPTN protein after infection (<xref rid="F4" ref-type="fig">Fig. 4F and H</xref>).</p><p id="P16">Generation of ROS by NADPH oxidase is important for the induction of autophagy, LC3 recruitment to phagosomes and restriction of intracellular replication of <italic>Salmonella</italic> Typhimurium (<xref rid="R28" ref-type="bibr">28</xref>). Consistent with our finding that <italic>Usp18<sup>Ity9</sup></italic> mice have deregulated autophagy marker expression following <italic>Salmonella</italic> infection <italic>in vivo</italic>, we also observed that <italic>Usp18<sup>Ity9</sup></italic> macrophages have decreased ROS production after exposure to heat-killed <italic>Salmonella</italic> (<xref rid="F4" ref-type="fig">Fig. 4I</xref>). Together, these data suggest that the diminished levels of ROS and OPTN result in a failure of autophagy to proceed, thus leading to an accumulation of p62 and lack of LC3 conversion.</p><p id="P17">To further demonstrate that type I IFN is important in the control of IL-10 and autophagy during <italic>Salmonella</italic> infection in <italic>Usp18<sup>Ity9</sup></italic> mutant mice, we investigated whether inhibition of Type I IFN in <italic>Usp18<sup>Ity9</sup></italic> mice would affect IL-10 levels in circulation. We found that the increase in IL-10 observed in <italic>Salmonella</italic>-infected mice given the IgG control was diminished in mice treated with the type I IFN neutralizing antibody (<xref rid="F4" ref-type="fig">Fig. 4J</xref>). Moreover, inhibition of type I IFN in mutant mice was also sufficient to restore levels of OPTN following <italic>Salmonella</italic> infection (<xref rid="F4" ref-type="fig">Fig. 4K</xref>). Together, these data support our hypothesis that IL-10 and autophagic marker levels are affected by the levels of type I IFN in <italic>Usp18<sup>Ity9</sup></italic> mice.</p></sec><sec id="S7"><title>Usp18<sup>Ity9</sup> mice have increased IL-1&#x003b2; and an elevated Th17 response</title><p id="P18">IL-1&#x003b2; is a pro-inflammatory cytokine important for innate immunity to <italic>Salmonella</italic> infection, but in excess, can result in endotoxemia (<xref rid="R29" ref-type="bibr">29</xref>). Autophagy regulates pro-IL-1&#x003b2; production and an accumulation of cellular p62 due to deficient autophagy can promote activation of NF-&#x003ba;B and subsequently induce pro-IL-1&#x003b2; (<xref rid="R30" ref-type="bibr">30</xref>). Therefore, we evaluated the impact of the <italic>Usp18<sup>Ity9</sup></italic> mutation on IL-1&#x003b2; expression. We found that <italic>Il1b</italic> transcript and pro-IL-1&#x003b2; protein levels were increased in <italic>Usp18<sup>Ity9</sup></italic> at 8 days post-infection (<xref rid="F5" ref-type="fig">Fig. 5A&#x02013;B</xref>). In addition, explanted splenocytes from <italic>Salmonella</italic> Typhimurium-infected mice produced more IL-1&#x003b2; compared to control mice (<xref rid="F5" ref-type="fig">Fig. 5C</xref>). Since IL-1&#x003b2; release can lead to an increase in IL-23 secretion, (<xref rid="R31" ref-type="bibr">31</xref>) and together, potently induce the secretion of IL-17 by Th17 cells (<xref rid="R32" ref-type="bibr">32</xref>), we next investigated the levels of these cytokines in <italic>Usp18<sup>Ity9</sup></italic> mice after <italic>Salmonella</italic> infection. We found that mutant mice had elevated levels of IL-23 and IL-17 transcript (<xref rid="F5" ref-type="fig">Fig. 5D&#x02013;E</xref>) and increased production of IL-17 from CD4<sup>+</sup> T cells (<xref rid="F5" ref-type="fig">Fig. 5F</xref>) showing that high IL-1&#x003b2; levels in <italic>Usp18<sup>Ity9</sup></italic> mutant mice induced a Th17 response.</p></sec><sec id="S8"><title>Usp18<sup>Ity9</sup> mice are susceptible to <italic>Mycobacterium tuberculosis</italic> infection</title><p id="P19">To further investigate the role of USP18 during bacterial infection, we tested whether the <italic>Ity9</italic> mutation would impact the susceptibility to another Gram-negative bacteria (<italic>Citrobacter rodentii</italic>) and mycobacteria (<italic>Mycobacterium bovis</italic> BCG and <italic>Mycobacterium Tuberculosis</italic>)<italic>. Usp18<sup>Ity9</sup></italic> were not susceptible to <italic>C. rodentium</italic> as measured by survival analysis (data not shown) and bacterial shedding (data not shown) and to <italic>M. bovis</italic> BCG (data not shown). In contrast, we found that <italic>Usp18<sup>Ity9</sup></italic> mice showed significantly increased susceptibility to infection compared to both wild-type littermates and DBA/2J mice following aerosol infection with the highly virulent <italic>M. tuberculosis</italic> H37Rv strain (<xref rid="F6" ref-type="fig">Fig. 6A</xref>). Decreased survival correlated with significantly higher bacterial burden in both the lung and spleen of <italic>M. tuberculosis</italic> infected <italic>Usp18<sup>Ity9</sup></italic> mice (<xref rid="F6" ref-type="fig">Fig. 6B</xref>). At necropsy 6 weeks post-infection, <italic>Usp18<sup>Ity9</sup></italic> mutant mice showed large infected foci with extensive necrotic centre and increased lymphohistiocytic inflammatory cell infiltration in the lung compared to littermate control mice with a greater percentage of the lung affected by inflammation (<xref rid="SD1" ref-type="supplementary-material">Supplemental Fig. 1</xref>, left and middle panels). Moreover, Zeihl-Neelsen staining of acid-fast bacilli revealed significantly more <italic>Mycobacterium tuberculosis</italic> bacteria in the lungs of mutant mice compared to wild-type controls (<xref rid="SD1" ref-type="supplementary-material">Supplemental Fig. 1</xref>, right panels). As observed during the course of <italic>Salmonella</italic> infection, <italic>Usp18<sup>Ity9</sup></italic>mice showed elevated levels of circulating ISG15 and several cytokines including IFN&#x003b3;, TNF&#x003b1;, and IL-10 (<xref rid="F6" ref-type="fig">Fig. 6D</xref>). In addition, <italic>Usp18<sup>Ity9</sup></italic>mice also showed increased lung mRNA expression of <italic>Il17</italic>, <italic>Il1b</italic> and <italic>Isg15</italic>, with no difference in the mRNA expression of <italic>Il10</italic> between wild-type and mutant mice (<xref rid="F6" ref-type="fig">Fig. 6E</xref>). Together, these observations suggest that <italic>Usp18<sup>Ity9</sup></italic> mutant mice are more susceptible to mycobacterial infection as a result of increased bacterial load and excessive inflammatory response.</p></sec></sec><sec sec-type="discussion" id="S9"><title>DISCUSSION</title><p id="P20">In the current paper we examined the contribution of the deISGylating and Type I IFN regulatory functions of <italic>Usp18<sup>Ity9</sup></italic> during <italic>Salmonella</italic> infection. Our <italic>in vitro</italic> and <italic>in vivo</italic> data are consistent with those from <italic>Usp18</italic> knockout mice where LPS-stimulated macrophages have increased ISGylation compared to wild-type mice (<xref rid="R33" ref-type="bibr">33</xref>). The robust expression of ISG15 and ISGylation in response to <italic>Salmonella</italic> infection due to the loss of USP18 activity does not appear to play a major role in susceptibility to infection of <italic>Usp18</italic> mutant mice. Loss of <italic>Isg15</italic> in <italic>Usp18<sup>Ity9</sup></italic> mutant mice does not impact on the <italic>in vivo</italic> susceptibility, suggesting that deregulation of the ISGylation pathway is not the predominant mechanism of susceptibility in <italic>Usp18<sup>Ity9</sup></italic> mice. The secretion of ISG15 from various immune cells suggests that in addition to its role as a ubiquitin-like molecule, ISG15 acts as a cytokine that synergizes with IL-12 to increase IFN&#x003b3; and provide protective immunity to infection (<xref rid="R34" ref-type="bibr">34</xref>&#x02013;<xref rid="R36" ref-type="bibr">36</xref>). Although the expression and secretion of IFN-&#x003b3; in <italic>Usp18<sup>Ity9</sup></italic> mutant mice was not affected by the high levels of ISG15, it is possible that the loss of ISG15 in its secreted form in the double <italic>Isg15</italic> and <italic>Usp18</italic> deficient mice may explain, in part, the inability to improve survival to infection. Indeed, <italic>Isg15</italic>deficient mice carrying a wild-type allele at <italic>Usp18</italic> showed increased susceptibility later during infection. Late susceptibility of <italic>Isg15</italic> deficient mice to <italic>Mycobacterium tuberculosis</italic> infection has been also reported (<xref rid="R35" ref-type="bibr">35</xref>). Identification of ISG15 substrate proteins, including those involved in adaptive immune responses, will provide insight on the mechanism of susceptibility later during bacterial infection.</p><p id="P21">On the other hand, our results indicate that <italic>Usp18<sup>Ity9</sup></italic> mice treated with a neutralizing antibody to the type I IFN receptor have improved survival and decreased bacterial load after <italic>Salmonella</italic> challenge. We have previously reported that signaling through the type I IFN pathway is deleterious to the host during <italic>Salmonella</italic> infection (<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R11" ref-type="bibr">11</xref>). In addition, IFNAR<sup>&#x02212;/&#x02212;</sup> mice are more resistant to infection with <italic>Salmonella</italic> Typhimurium as a result of increased macrophage necroptosis thereby permitting evasion of the host response (<xref rid="R37" ref-type="bibr">37</xref>). Type I IFNs have been shown to be detrimental to the host during bacterial infection through a number of mechanisms including chemokine production, leukocyte recruitment, T cell responses and host cell apoptosis, among others (reviewed in (<xref rid="R6" ref-type="bibr">6</xref>), suggesting that the mechanisms underlying the action of type I IFN are complex.</p><p id="P22">In <italic>Usp18</italic> mutant mice, the proinflammatory immune response to infection becomes amplified and dysregulated as shown by excessive production of the cytokines IL-1&#x003b2; and IL-6 These cytokines most likely act in synergy with other cytokines (IFN&#x003b3; and TNF) that were also upregulated during infection, to cause septic shock, tissue damage, and death. In parallel, we showed that <italic>Usp18<sup>Ity9</sup></italic> mice have elevated systemic IL-10. IL-10 is an anti-inflammatory cytokine that prevents damage to the host. IL-10 works in opposition to IL-6, which also signals through STAT3 (<xref rid="R38" ref-type="bibr">38</xref>). The activation of IL-10 signaling does not appear to repress the expression of proinflammatory genes in <italic>Usp18</italic> mutant mice although decreased ROS production <italic>in vitro</italic> was observed, which is consistent with studies showing that IL-10 inhibits ROS production in LPS-stimulated macrophages and neutrophils (<xref rid="R39" ref-type="bibr">39</xref>, <xref rid="R40" ref-type="bibr">40</xref>). The attenuated oxidative burst activity in <italic>Usp18</italic> mutant mice may well explain the higher bacterial load observed in the spleens and livers of these animals.</p><p id="P23">In our model of infection, IL-1&#x003b2; is increased at both the transcript and protein levels in the spleen of infected mice, which contrasts with the observation that IFN-&#x003b2; is able to limit pro-IL-1&#x003b2; availability and IL-1&#x003b2; maturation (<xref rid="R23" ref-type="bibr">23</xref>) and that elevated type I IFN inhibits <italic>M. tuberculosis</italic>-induced IL-1&#x003b2; mRNA expression in macrophages (<xref rid="R41" ref-type="bibr">41</xref>). Moreover, type I IFN was shown to inhibit production of IL-1&#x003b2; from myeloid cells <italic>in vivo</italic> (<xref rid="R42" ref-type="bibr">42</xref>), resulting in a loss of IL-1&#x003b2;-mediated control of bacterial burden (<xref rid="R43" ref-type="bibr">43</xref>). This discrepancy may be attributed to an increase in p62 post-infection in <italic>Usp18<sup>Ity9</sup></italic> mice since accumulation of p62 and subsequent activation of NF-&#x003ba;B has been shown to increase IL-1&#x003b2; (<xref rid="R30" ref-type="bibr">30</xref>). We do observe an increase in IL-23 and IL-17 in the spleen <italic>Usp18<sup>Ity9</sup></italic> mutant mice which is consistent with reports of an IL-1&#x003b2;-dependent increase in IL-23 resulting in enhanced IL-17 secretion from T cells (<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R32" ref-type="bibr">32</xref>). USP18 was recently shown to play an important role in adaptive immunity by controlling Th17 cell differentiation (<xref rid="R44" ref-type="bibr">44</xref>). USP18 knock out T cells were shown to be deficient in Th17 differentiation, which contrasts with our observation that <italic>Usp18<sup>Ity9</sup></italic> mutant mice had elevated levels of <italic>Il17</italic> transcript and increased production of IL-17 from CD4<sup>+</sup> T cells during <italic>Salmonella</italic> infection. This apparent discrepancy could be explained by the fact that the <italic>Usp18<sup>Ity9</sup></italic> mutation does not affect the peptidase domain of USP18 and Liu <italic>et al.</italic> reported that the enzymatic activity of USP18 was important for controlling Th17 differentiation. The exact mechanism underlying increased IL-1&#x003b2; and IL-17 in <italic>Usp18<sup>Ity9</sup></italic> mutant mice is not fully understood, however, we suggest that inhibition of autophagy by type I IFN signaling may be one of the mechanisms. This hypothesis is based on the reported observations that inhibition of autophagy promotes inflammasome activity and increases IL-1&#x003b2; production (<xref rid="R45" ref-type="bibr">45</xref>) and that IL-17 is increased in <italic>M. tuberculosis</italic> infected mice deficient in autophagy (<xref rid="R46" ref-type="bibr">46</xref>) and a prolonged Th17 response contributes to the pathogenesis of the infection (<xref rid="R47" ref-type="bibr">47</xref>). Autophagic degradation of intracellular bacteria is an important host defense mechanism during infection. Recently, invading <italic>Salmonella</italic> were shown to induce a transient amino acid starvation as a result of membrane damage leading to the induction of autophagy and host protection (<xref rid="R48" ref-type="bibr">48</xref>). Yet, <italic>Salmonella</italic> effector molecules including SseL, a deubiquitinase, and SopD2, a regulator of SCV integrity, contribute to the inhibition of autophagy during infection (<xref rid="R49" ref-type="bibr">49</xref>, <xref rid="R50" ref-type="bibr">50</xref>), suggesting that bacterial evasion of the host autophagic response is key to bacterial replication. Low levels of autophagy lead to accumulation of p62 and decreased LC3II (<xref rid="R51" ref-type="bibr">51</xref>). Thus, the increased p62 and decreased LC3II observed in <italic>Usp18<sup>Ity9</sup></italic> mice <italic>in vivo</italic> raises the possibility that autophagy may be impaired in <italic>Usp18<sup>Ity9</sup></italic> mutant mice although a more comprehensive evaluation of autophagy <italic>in vitro</italic> will be necessary to draw a final conclusion.</p><p id="P24">The role of type I IFN in the regulation of mycobacteria infections is highlighted by recent studies showing that IFNAR<sup>&#x02212;/&#x02212;</sup> mice are more resistant to <italic>M. tuberculosis</italic> infection and that patients with active tuberculosis have a characteristic IFN-inducible gene signature (<xref rid="R52" ref-type="bibr">52</xref>, <xref rid="R53" ref-type="bibr">53</xref>). An increase in the type I IFN response was also reported in lepromatous leprosy skin lesions when compared to self-healing tuberculoid lesions caused by <italic>Mycobacterium leprae in vivo</italic> (<xref rid="R54" ref-type="bibr">54</xref>). We show in the current paper that <italic>Usp18<sup>Ity9</sup></italic> mice are more susceptible to <italic>Mycobacterium tuberculosis</italic> infection and have increased bacterial load in lung and spleen, elevated inflammatory cytokine production and more severe lung pathology. As shown during <italic>Salmonella</italic> infection and in contrast with previous studies (<xref rid="R35" ref-type="bibr">35</xref>), the increases in circulating ISG15 and IFN&#x003b3; do not appear to be protective during infection in <italic>Usp18<sup>Ity9</sup></italic> mice. This finding demonstrates that USP18 plays a broad role during infection with intracellular bacteria, additional studies will provide further insight into the mechanism of susceptibility in <italic>Usp18<sup>Ity9</sup></italic>mice during mycobacterial disease.</p><p id="P25">In summary, this work describes the biological significance of type I IFN signaling in the survival of <italic>Usp18<sup>Ity9</sup></italic> mice following <italic>Salmonella</italic> infection and outlines a model of susceptibility resulting from increase in proinflammatory cytokine production as a consequence of hyperactivation of type I IFN signaling, and increased IL-10 production, leading to deregulated expression of IL-1&#x003b2; and autophagy markers that results in increased bacterial burden and septic shock in <italic>Salmonella</italic>-infected <italic>Usp18<sup>Ity9</sup></italic> mice. Our studies reveal that a mutation in human USP18 corresponding to the <italic>Usp18<sup>Ity9</sup></italic> mutation also affects the enzymatic and regulatory functions of USP18, suggesting that the findings presented here may be relevant to the function of human USP18 during infection.</p></sec><sec sec-type="materials|methods" id="S10"><title>MATERIALS AND METHODS</title><sec id="S11"><title>Ethics Statement</title><p id="P26">All animal experiments were performed under guidelines specified by the Canadian Council on Animal Care. The animal use protocol was approved by the McGill University Animal Care Committee (protocol #5797).</p></sec><sec id="S12"><title>Mice</title><p id="P27">The <italic>Usp18<sup>Ity9</sup></italic> mutation was originally identified on a mixed C57BL/6 &#x000d7; 129S1/SvImJ &#x000d7; DBA/2J genetic background (37.5%, 37.5%, 25%, respectively). Backcrossing from the original mixed background was accomplished by nine generations of inbreeding to the 129S1 or DBA/2J strains (Jackson Laboratories), resulting in mice that are &#x0003e;99.8% 129S1 or DBA/2J. <italic>Isg15</italic> knockout (B6.129P2-<italic>Isg15<sup>tm1Kpk</sup></italic>/J; Jackson Laboratories) were crossed with <italic>Usp18<sup>+/+</sup></italic> or <italic>Usp18<sup>Ity9</sup></italic> mice to generate F1 mice that were heterozygous for <italic>Isg15</italic> and <italic>Usp18<sup>Ity9</sup></italic> or the wild-type allele. These mice were intercrossed to generate mice that were homozygous for <italic>Usp18<sup>Ity9</sup></italic> or the wild-type allele and selected for wild-type <italic>Slc11a1</italic>. Mice were bred at the Goodman Cancer Research Centre Animal Facility.</p></sec><sec id="S13"><title>In vivo <italic>Salmonella</italic> infections</title><p id="P28">Mice between 7&#x02013;12 weeks of age were infected intravenously with <italic>Salmonella</italic> Typhimurium strain Keller, as described by us previously (<xref rid="R3" ref-type="bibr">3</xref>). Mice were infected in the caudal vein and monitored twice daily for survival. Alternatively, spleens and livers were collected, homogenized in saline and CFUs were determined by plating of serial dilutions on trypticase soy agar plates.</p></sec><sec id="S14"><title>ELISA</title><p id="P29">Serum was obtained from the blood of infected mice and cytokines were assayed by ELISA (eBioscience) according to the manufacturers directions.</p></sec><sec id="S15"><title>RNA extraction and quantitative RT-PCR</title><p id="P30">Total RNA was isolated from mouse tissue using the TRIzol reagent (Invitrogen Life Technologies). First-strand cDNA was generated using MMLV-RT (Invitrogen) and random oligonucleotides as primers. Quantitative PCR was performed in duplicate for each transcript using SYBR<sup>&#x000ae;</sup> green qPCR master mix (Applied Biosystems) on a StepOnePlus apparatus (Applied Biosystems). The Ct values for the genes of interest were normalized to the housekeeping gene TATA-binding protein (TBP). The relative expression of the gene was calculated as 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup>.</p></sec><sec id="S16"><title>Bone marrow-derived macrophages</title><p id="P31">Femurs were collected from 8&#x02013;12 week old mice and bone marrow was extracted by flushing the femurs with RPMI using a 25-G needle. A single-cell suspension was obtained by passage through a 25-G needle and RBCs lysed for 5 min using a commercial RBC Lysis Buffer (Sigma-Aldrich). Cells were resuspended in complete medium (RPMI supplemented with 10% heat-inactivated FBS, 2 mM glutamine, 100 &#x003bc;g/mL Penstrep and 30% L929 conditioned medium as a source of murine CSF. L929 supernatant was replenished every 2 days prior to cell counting and plating.</p></sec><sec id="S17"><title>Immunoblotting</title><p id="P32">Protein lysates were prepared using the CellLytic-M reagent (Sigma-Aldrich) according to the manufacturers directions. Proteins were quantified by the Bradford method (Bio-Rad) and Western blotting was carried out using 25&#x02013;50 &#x003bc;g of protein resolved by SDS-PAGE, transferred to PVDF membrane and immunoblotted as indicated. &#x003b2;-actin was used to assess protein loading.</p></sec><sec id="S18"><title>Plasmids and transfection</title><p id="P33">The wild type USP18 expression constructs were described previously (<xref rid="R55" ref-type="bibr">55</xref>). USP18<sup>L365F</sup> mutant constructs were generated by site directed mutagenesis. ISG15 isopeptidase activity and type I IFN inhibitor activity of wild type and mutant USP18 were examined using an ex vivo ISGylation system in 293T cells and in HeLa cells, respectively, as described previously (<xref rid="R55" ref-type="bibr">55</xref>, <xref rid="R56" ref-type="bibr">56</xref>).</p></sec><sec id="S19"><title>MAR1-5A3 treatment</title><p id="P34">Mice were pretreated with 2 mg of either MAR1-5A3 or mouse IgG<sub>1</sub> isotype control antibody (Leinco Technologies, Inc.) 1 day prior to infection with 1000 CFUs of <italic>Salmonella</italic> Typhimurium.</p></sec><sec id="S20"><title>Flow cytometry</title><p id="P35">Spleens were harvested from 8&#x02013;12 week old mice, macerated and passaged through a 70 &#x003bc;M cell strainer. RBC lysis was performed using ACK lysing buffer and cells were enumerated and plated for ELISA or for flow cytometry. Intracellular staining of IL-17 (eBioscience) was performed on prepared splenocytes (10 &#x000d7; 10<sup>6</sup> cells) using CytoFix/CytoPerm (BD Biosciences). Briefly, cells were stimulated <italic>in vitro</italic> (4 h) with PMA (50 ng/mL; Sigma-Aldrich) and Ionomycin (500 ng/mL; Sigma-Aldrich) and intracellular transport was inhibited using GolgiStop (BD Biosciences). Cells were stained with antibodies to CD4, CD3, B220 and IL-17 and gating was performed to include CD3<sup>+</sup>CD4<sup>+</sup>B220<sup>&#x02212;</sup>IL-17<sup>+</sup> cells. All samples were analysed using a FACSCanto (BD Biosciences) with FlowJo software (Tree Star).</p></sec><sec id="S21"><title>ROS measurements</title><p id="P36">BMDM were plated in non-tissue-culture treated six-well dishes and infected with heat-killed Salmonella (MOI = 50, 6 h). Complete DMEM was aspirated, cells were washed with PBS and incubated with CM-H<sub>2</sub>DCFDA (10 &#x003bc;M, 30 min; Invitrogen) in serum-free medium. Cells were washed with warm PBS, then removed from the well using cold PBS containing 10 mM EDTA, pelleted at 1200 r.p.m., resuspended in cold PBS containing 1% FBS and analysed using a FACSCanto (BD Biosciences) with FlowJo software (Tree Star). Mean fluorescence intensity values were calculated as fold change over uninfected cells.</p></sec><sec id="S22"><title><italic>In vivo Mycobacterium tuberculosis</italic> infections</title><p id="P37"><italic>Mycobacterium tuberculosis</italic> H37Rv was grown at 37&#x000b0;C in Middlebrook 7H9 medium (Difco Laboratories) containing 0.05% Tween-20 (Sigma-Aldrich) and 10% albumin-dextrase-catalase (ADC) supplement (Becton Dickson and Co.). Bacteria were delivered by aerosol using an inhalation exposure system (In-Tox Products) and infectious dose was confirmed by enumeration of bacteria within the lungs of control mice at 24 hours post-infection. Mice were euthanized at 6 weeks post-infection, organs were homogenized in PBS and bacterial burden was determined by serial dilution on Middlebrook 7H10 agar (Difco Laboratories) plates supplemented with OADC enrichment (Becton Dickson and Co.) and BacTac Panta Plus (Becton Dickson and Co.). Serum was collected for ELISA and tissues were either fixed in buffered formalin prior to immunohistochemical analysis or stored in RNA later (Ambion). For histology, representative slides were assessed by a pathologist and scored for degree of inflammation.</p></sec><sec id="S23"><title>Statistical Analyses</title><p id="P38">Results are expressed as means &#x000b1; s.e.m. Data were analysed using a two-tailed Student&#x02019;s <italic>t</italic>-test using the GraphPad Prism statistical program. P values of less than 0.05 were considered significant.</p></sec></sec><sec sec-type="supplementary-material" id="S24"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS4329-supplement-1.pptx" orientation="portrait" xlink:type="simple" id="d36e1737" position="anchor"/></supplementary-material></sec></body><back><ack id="S25"><p>We are grateful for the technical assistance of Nadia Prud&#x02019;homme, Patricia D&#x02019;arcy, Genevieve Perrault, Lei Zhu, Kyoko Yuki and Line Larivi&#x000e8;re. SMD is the recipient of a fellowship award from the Fonds de la recherche en sant&#x000e9; du Qu&#x000e9;bec. This work was supported by a Canadian Institutes of Health Research Team Grant (CTP-87520) to DM and PG, as well as a United States NIH HL091549 to DEZ. PG is a James McGill Professor and DM is a McGill Dawson Scholar.</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p><bold>CONFLICT OF INTEREST</bold></p><p>The authors declare no conflict of interest.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crump</surname><given-names>JA</given-names></name><name><surname>Mintz</surname><given-names>ED</given-names></name></person-group><article-title>Global trends in typhoid and paratyphoid Fever</article-title><source>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</source><year>2010</year><volume>50</volume><issue>2</issue><fpage>241</fpage><lpage>6</lpage><comment>Epub 2009/12/18</comment><pub-id pub-id-type="pmid">20014951</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>SM</given-names></name><name><surname>Malo</surname><given-names>D</given-names></name><name><surname>Marquis</surname><given-names>JF</given-names></name><name><surname>Gros</surname><given-names>P</given-names></name></person-group><article-title>Forward genetic dissection of immunity to infection in the mouse</article-title><source>Annual review of immunology</source><year>2008</year><volume>26</volume><fpage>81</fpage><lpage>132</lpage><comment>Epub 2007/10/24</comment></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richer</surname><given-names>E</given-names></name><name><surname>Prendergast</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>DE</given-names></name><name><surname>Qureshi</surname><given-names>ST</given-names></name><name><surname>Vidal</surname><given-names>SM</given-names></name><name><surname>Malo</surname><given-names>D</given-names></name></person-group><article-title>N-ethyl-N-nitrosourea-induced mutation in ubiquitin-specific peptidase 18 causes hyperactivation of IFN-alphass signaling and suppresses STAT4-induced IFN-gamma production, resulting in increased susceptibility to Salmonella typhimurium</article-title><source>J Immunol</source><year>2010</year><volume>185</volume><issue>6</issue><fpage>3593</fpage><lpage>601</lpage><comment>Epub 2010/08/10</comment><pub-id pub-id-type="pmid">20693420</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malakhova</surname><given-names>OA</given-names></name><name><surname>Kim</surname><given-names>KI</given-names></name><name><surname>Luo</surname><given-names>JK</given-names></name><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>Kumar</surname><given-names>KG</given-names></name><name><surname>Fuchs</surname><given-names>SY</given-names></name><etal/></person-group><article-title>UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity</article-title><source>The EMBO journal</source><year>2006</year><volume>25</volume><issue>11</issue><fpage>2358</fpage><lpage>67</lpage><comment>Epub 2006/05/20</comment><pub-id pub-id-type="pmid">16710296</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KI</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Malakhova</surname><given-names>O</given-names></name><name><surname>Luo</surname><given-names>JK</given-names></name><name><surname>Shen</surname><given-names>MF</given-names></name><name><surname>Zou</surname><given-names>W</given-names></name><etal/></person-group><article-title>Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling</article-title><source>Molecular and cellular biology</source><year>2006</year><volume>26</volume><issue>2</issue><fpage>472</fpage><lpage>9</lpage><comment>Epub 2005/12/31</comment><pub-id pub-id-type="pmid">16382139</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group><article-title>Type I interferon: friend or foe?</article-title><source>The Journal of experimental medicine</source><year>2010</year><volume>207</volume><issue>10</issue><fpage>2053</fpage><lpage>63</lpage><comment>Epub 2010/09/15</comment><pub-id pub-id-type="pmid">20837696</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>T</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Stockinger</surname><given-names>S</given-names></name></person-group><article-title>The yin and yang of type I interferon activity in bacterial infection</article-title><source>Nature reviews Immunology</source><year>2005</year><volume>5</volume><issue>9</issue><fpage>675</fpage><lpage>87</lpage><comment>Epub 2005/08/20</comment></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayamajhi</surname><given-names>M</given-names></name><name><surname>Humann</surname><given-names>J</given-names></name><name><surname>Penheiter</surname><given-names>K</given-names></name><name><surname>Andreasen</surname><given-names>K</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group><article-title>Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma</article-title><source>The Journal of experimental medicine</source><year>2010</year><volume>207</volume><issue>2</issue><fpage>327</fpage><lpage>37</lpage><comment>Epub 2010/02/04</comment><pub-id pub-id-type="pmid">20123961</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dikopoulos</surname><given-names>N</given-names></name><name><surname>Bertoletti</surname><given-names>A</given-names></name><name><surname>Kroger</surname><given-names>A</given-names></name><name><surname>Hauser</surname><given-names>H</given-names></name><name><surname>Schirmbeck</surname><given-names>R</given-names></name><name><surname>Reimann</surname><given-names>J</given-names></name></person-group><article-title>Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells</article-title><source>J Immunol</source><year>2005</year><volume>174</volume><issue>1</issue><fpage>99</fpage><lpage>109</lpage><comment>Epub 2004/12/22</comment><pub-id pub-id-type="pmid">15611232</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brzoza-Lewis</surname><given-names>KL</given-names></name><name><surname>Hoth</surname><given-names>JJ</given-names></name><name><surname>Hiltbold</surname><given-names>EM</given-names></name></person-group><article-title>Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes</article-title><source>Cellular immunology</source><year>2012</year><volume>273</volume><issue>1</issue><fpage>41</fpage><lpage>51</lpage><comment>Epub 2012/01/04</comment><pub-id pub-id-type="pmid">22212606</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>R</given-names></name><name><surname>Sancho-Shimizu</surname><given-names>V</given-names></name><name><surname>Prendergast</surname><given-names>C</given-names></name><name><surname>Roy</surname><given-names>MF</given-names></name><name><surname>Loredo-Osti</surname><given-names>JC</given-names></name><name><surname>Malo</surname><given-names>D</given-names></name></person-group><article-title>Refinement of the genetics of the host response to Salmonella infection in MOLF/Ei: regulation of type 1 IFN and TRP3 pathways by Ity2</article-title><source>Genes and immunity</source><year>2012</year><volume>13</volume><issue>2</issue><fpage>175</fpage><lpage>83</lpage><comment>Epub 2011/10/01</comment><pub-id pub-id-type="pmid">21956657</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deretic</surname><given-names>V</given-names></name></person-group><article-title>Autophagy in immunity and cell-autonomous defense against intracellular microbes</article-title><source>Immunological reviews</source><year>2011</year><volume>240</volume><issue>1</issue><fpage>92</fpage><lpage>104</lpage><comment>Epub 2011/02/26</comment><pub-id pub-id-type="pmid">21349088</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrin</surname><given-names>AJ</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Birmingham</surname><given-names>CL</given-names></name><name><surname>So</surname><given-names>NS</given-names></name><name><surname>Brumell</surname><given-names>JH</given-names></name></person-group><article-title>Recognition of bacteria in the cytosol of Mammalian cells by the ubiquitin system</article-title><source>Current biology : CB</source><year>2004</year><volume>14</volume><issue>9</issue><fpage>806</fpage><lpage>11</lpage><comment>Epub 2004/05/04</comment><pub-id pub-id-type="pmid">15120074</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birmingham</surname><given-names>CL</given-names></name><name><surname>Smith</surname><given-names>AC</given-names></name><name><surname>Bakowski</surname><given-names>MA</given-names></name><name><surname>Yoshimori</surname><given-names>T</given-names></name><name><surname>Brumell</surname><given-names>JH</given-names></name></person-group><article-title>Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole</article-title><source>The Journal of biological chemistry</source><year>2006</year><volume>281</volume><issue>16</issue><fpage>11374</fpage><lpage>83</lpage><comment>Epub 2006/02/24</comment><pub-id pub-id-type="pmid">16495224</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>YT</given-names></name><name><surname>Shahnazari</surname><given-names>S</given-names></name><name><surname>Brech</surname><given-names>A</given-names></name><name><surname>Lamark</surname><given-names>T</given-names></name><name><surname>Johansen</surname><given-names>T</given-names></name><name><surname>Brumell</surname><given-names>JH</given-names></name></person-group><article-title>The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway</article-title><source>J Immunol</source><year>2009</year><volume>183</volume><issue>9</issue><fpage>5909</fpage><lpage>16</lpage><comment>Epub 2009/10/09</comment><pub-id pub-id-type="pmid">19812211</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>P</given-names></name><name><surname>Farhan</surname><given-names>H</given-names></name><name><surname>McEwan</surname><given-names>DG</given-names></name><name><surname>Wagner</surname><given-names>S</given-names></name><name><surname>Rogov</surname><given-names>VV</given-names></name><name><surname>Brady</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth</article-title><source>Science</source><year>2011</year><volume>333</volume><issue>6039</issue><fpage>228</fpage><lpage>33</lpage><comment>Epub 2011/05/28</comment><pub-id pub-id-type="pmid">21617041</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurston</surname><given-names>TL</given-names></name><name><surname>Ryzhakov</surname><given-names>G</given-names></name><name><surname>Bloor</surname><given-names>S</given-names></name><name><surname>von Muhlinen</surname><given-names>N</given-names></name><name><surname>Randow</surname><given-names>F</given-names></name></person-group><article-title>The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria</article-title><source>Nature immunology</source><year>2009</year><volume>10</volume><issue>11</issue><fpage>1215</fpage><lpage>21</lpage><comment>Epub 2009/10/13</comment><pub-id pub-id-type="pmid">19820708</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>J</given-names></name></person-group><article-title>Autophagy and cytokines</article-title><source>Cytokine</source><year>2011</year><volume>56</volume><issue>2</issue><fpage>140</fpage><lpage>4</lpage><comment>Epub 2011/09/06</comment><pub-id pub-id-type="pmid">21889357</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malakhov</surname><given-names>MP</given-names></name><name><surname>Malakhova</surname><given-names>OA</given-names></name><name><surname>Kim</surname><given-names>KI</given-names></name><name><surname>Ritchie</surname><given-names>KJ</given-names></name><name><surname>Zhang</surname><given-names>DE</given-names></name></person-group><article-title>UBP43 (USP18) specifically removes ISG15 from conjugated proteins</article-title><source>The Journal of biological chemistry</source><year>2002</year><volume>277</volume><issue>12</issue><fpage>9976</fpage><lpage>81</lpage><comment>Epub 2002/01/15</comment><pub-id pub-id-type="pmid">11788588</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>DE</given-names></name></person-group><article-title>Interferon-stimulated gene 15 and the protein ISGylation system</article-title><source>Journal of interferon &#x00026; cytokine research : the official journal of the International Society for Interferon and Cytokine Research</source><year>2011</year><volume>31</volume><issue>1</issue><fpage>119</fpage><lpage>30</lpage><comment>Epub 2010/12/31</comment></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>MF</given-names></name><name><surname>Malo</surname><given-names>D</given-names></name></person-group><article-title>Genetic regulation of host responses to Salmonella infection in mice</article-title><source>Genes and immunity</source><year>2002</year><volume>3</volume><issue>7</issue><fpage>381</fpage><lpage>93</lpage><comment>Epub 2002/11/09</comment><pub-id pub-id-type="pmid">12424619</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>KC</given-names></name><name><surname>Lai</surname><given-names>KS</given-names></name><name><surname>Dunn</surname><given-names>GP</given-names></name><name><surname>Bruce</surname><given-names>AT</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><name><surname>Heutel</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection</article-title><source>Journal of interferon &#x00026; cytokine research : the official journal of the International Society for Interferon and Cytokine Research</source><year>2006</year><volume>26</volume><issue>11</issue><fpage>804</fpage><lpage>19</lpage><comment>Epub 2006/11/23</comment></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarda</surname><given-names>G</given-names></name><name><surname>Braun</surname><given-names>M</given-names></name><name><surname>Staehli</surname><given-names>F</given-names></name><name><surname>Tardivel</surname><given-names>A</given-names></name><name><surname>Mattmann</surname><given-names>C</given-names></name><name><surname>Forster</surname><given-names>I</given-names></name><etal/></person-group><article-title>Type I interferon inhibits interleukin-1 production and inflammasome activation</article-title><source>Immunity</source><year>2011</year><volume>34</volume><issue>2</issue><fpage>213</fpage><lpage>23</lpage><comment>Epub 2011/02/26</comment><pub-id pub-id-type="pmid">21349431</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finbloom</surname><given-names>DS</given-names></name><name><surname>Winestock</surname><given-names>KD</given-names></name></person-group><article-title>IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><issue>3</issue><fpage>1079</fpage><lpage>90</lpage><comment>Epub 1995/08/01</comment><pub-id pub-id-type="pmid">7543512</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Bae</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway</article-title><source>Molecular immunology</source><year>2011</year><volume>48</volume><issue>4</issue><fpage>720</fpage><lpage>7</lpage><comment>Epub 2010/11/26</comment><pub-id pub-id-type="pmid">21095008</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klionsky</surname><given-names>DJ</given-names></name><name><surname>Abdalla</surname><given-names>FC</given-names></name><name><surname>Abeliovich</surname><given-names>H</given-names></name><name><surname>Abraham</surname><given-names>RT</given-names></name><name><surname>Acevedo-Arozena</surname><given-names>A</given-names></name><name><surname>Adeli</surname><given-names>K</given-names></name><etal/></person-group><article-title>Guidelines for the use and interpretation of assays for monitoring autophagy</article-title><source>Autophagy</source><year>2012</year><volume>8</volume><issue>4</issue><fpage>445</fpage><lpage>544</lpage><comment>Epub 2012/09/12</comment><pub-id pub-id-type="pmid">22966490</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kageyama</surname><given-names>S</given-names></name><name><surname>Omori</surname><given-names>H</given-names></name><name><surname>Saitoh</surname><given-names>T</given-names></name><name><surname>Sone</surname><given-names>T</given-names></name><name><surname>Guan</surname><given-names>JL</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><etal/></person-group><article-title>The LC3 recruitment mechanism is separate from Atg9L1-dependent membrane formation in the autophagic response against Salmonella</article-title><source>Molecular biology of the cell</source><year>2011</year><volume>22</volume><issue>13</issue><fpage>2290</fpage><lpage>300</lpage><comment>Epub 2011/04/29</comment><pub-id pub-id-type="pmid">21525242</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Canadien</surname><given-names>V</given-names></name><name><surname>Lam</surname><given-names>GY</given-names></name><name><surname>Steinberg</surname><given-names>BE</given-names></name><name><surname>Dinauer</surname><given-names>MC</given-names></name><name><surname>Magalhaes</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Activation of antibacterial autophagy by NADPH oxidases</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2009</year><volume>106</volume><issue>15</issue><fpage>6226</fpage><lpage>31</lpage><comment>Epub 2009/04/03</comment><pub-id pub-id-type="pmid">19339495</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raupach</surname><given-names>B</given-names></name><name><surname>Peuschel</surname><given-names>SK</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name><name><surname>Zychlinsky</surname><given-names>A</given-names></name></person-group><article-title>Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection</article-title><source>Infection and immunity</source><year>2006</year><volume>74</volume><issue>8</issue><fpage>4922</fpage><lpage>6</lpage><comment>Epub 2006/07/25</comment><pub-id pub-id-type="pmid">16861683</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Quinley</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Gonzalez-Navajas</surname><given-names>J</given-names></name><name><surname>Xavier</surname><given-names>R</given-names></name><etal/></person-group><article-title>Autophagy suppresses interleukin-1beta (IL-1beta) signaling by activation of p62 degradation via lysosomal and proteasomal pathways</article-title><source>The Journal of biological chemistry</source><year>2012</year><volume>287</volume><issue>6</issue><fpage>4033</fpage><lpage>40</lpage><comment>Epub 2011/12/15</comment><pub-id pub-id-type="pmid">22167182</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peral de Castro</surname><given-names>C</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Ni Cheallaigh</surname><given-names>C</given-names></name><name><surname>Hearnden</surname><given-names>CA</given-names></name><name><surname>Williams</surname><given-names>L</given-names></name><name><surname>Winter</surname><given-names>J</given-names></name><etal/></person-group><article-title>Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion</article-title><source>J Immunol</source><year>2012</year><volume>189</volume><issue>8</issue><fpage>4144</fpage><lpage>53</lpage><comment>Epub 2012/09/14</comment><pub-id pub-id-type="pmid">22972933</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>CE</given-names></name><name><surname>Lalor</surname><given-names>SJ</given-names></name><name><surname>Sweeney</surname><given-names>CM</given-names></name><name><surname>Brereton</surname><given-names>CF</given-names></name><name><surname>Lavelle</surname><given-names>EC</given-names></name><name><surname>Mills</surname><given-names>KH</given-names></name></person-group><article-title>Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity</article-title><source>Immunity</source><year>2009</year><volume>31</volume><issue>2</issue><fpage>331</fpage><lpage>41</lpage><comment>Epub 2009/08/18</comment><pub-id pub-id-type="pmid">19682929</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KI</given-names></name><name><surname>Malakhova</surname><given-names>OA</given-names></name><name><surname>Hoebe</surname><given-names>K</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Beutler</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>DE</given-names></name></person-group><article-title>Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><issue>2</issue><fpage>847</fpage><lpage>54</lpage><comment>Epub 2005/07/09</comment><pub-id pub-id-type="pmid">16002682</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>E</given-names><suffix>Jr</suffix></name><name><surname>Cordova</surname><given-names>B</given-names></name></person-group><article-title>IFN-induced 15-kDa protein is released from human lymphocytes and monocytes</article-title><source>J Immunol</source><year>1991</year><volume>146</volume><issue>7</issue><fpage>2280</fpage><lpage>4</lpage><comment>Epub 1991/04/01</comment><pub-id pub-id-type="pmid">2005397</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogunovic</surname><given-names>D</given-names></name><name><surname>Byun</surname><given-names>M</given-names></name><name><surname>Durfee</surname><given-names>LA</given-names></name><name><surname>Abhyankar</surname><given-names>A</given-names></name><name><surname>Sanal</surname><given-names>O</given-names></name><name><surname>Mansouri</surname><given-names>D</given-names></name><etal/></person-group><article-title>Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency</article-title><source>Science</source><year>2012</year><volume>337</volume><issue>6102</issue><fpage>1684</fpage><lpage>8</lpage><comment>Epub 2012/08/04</comment><pub-id pub-id-type="pmid">22859821</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Cunha</surname><given-names>J</given-names></name><name><surname>Knight</surname><given-names>E</given-names><suffix>Jr</suffix></name><name><surname>Haas</surname><given-names>AL</given-names></name><name><surname>Truitt</surname><given-names>RL</given-names></name><name><surname>Borden</surname><given-names>EC</given-names></name></person-group><article-title>Immunoregulatory properties of ISG15, an interferon-induced cytokine</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1996</year><volume>93</volume><issue>1</issue><fpage>211</fpage><lpage>5</lpage><comment>Epub 1996/01/09</comment><pub-id pub-id-type="pmid">8552607</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>N</given-names></name><name><surname>McComb</surname><given-names>S</given-names></name><name><surname>Mulligan</surname><given-names>R</given-names></name><name><surname>Dudani</surname><given-names>R</given-names></name><name><surname>Krishnan</surname><given-names>L</given-names></name><name><surname>Sad</surname><given-names>S</given-names></name></person-group><article-title>Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium</article-title><source>Nature immunology</source><year>2012</year><volume>13</volume><issue>10</issue><fpage>954</fpage><lpage>62</lpage><comment>Epub 2012/08/28</comment><pub-id pub-id-type="pmid">22922364</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adib-Conquy</surname><given-names>M</given-names></name><name><surname>Cavaillon</surname><given-names>JM</given-names></name></person-group><article-title>Compensatory anti-inflammatory response syndrome</article-title><source>Thrombosis and haemostasis</source><year>2009</year><volume>101</volume><issue>1</issue><fpage>36</fpage><lpage>47</lpage><comment>Epub 2009/01/10</comment><pub-id pub-id-type="pmid">19132187</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dokka</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Leonard</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Castranova</surname><given-names>V</given-names></name><name><surname>Rojanasakul</surname><given-names>Y</given-names></name></person-group><article-title>Interleukin-10-mediated inhibition of free radical generation in macrophages</article-title><source>American journal of physiology Lung cellular and molecular physiology</source><year>2001</year><volume>280</volume><issue>6</issue><fpage>L1196</fpage><lpage>202</lpage><comment>Epub 2001/05/15</comment><pub-id pub-id-type="pmid">11350798</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussolati</surname><given-names>B</given-names></name><name><surname>Mariano</surname><given-names>F</given-names></name><name><surname>Montrucchio</surname><given-names>G</given-names></name><name><surname>Piccoli</surname><given-names>G</given-names></name><name><surname>Camussi</surname><given-names>G</given-names></name></person-group><article-title>Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes</article-title><source>Immunology</source><year>1997</year><volume>90</volume><issue>3</issue><fpage>440</fpage><lpage>7</lpage><comment>Epub 1997/03/01</comment><pub-id pub-id-type="pmid">9155653</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A</given-names></name><name><surname>Cardone</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>R</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>Kirschman</surname><given-names>KD</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1beta production in human macrophages</article-title><source>J Immunol</source><year>2011</year><volume>187</volume><issue>5</issue><fpage>2540</fpage><lpage>7</lpage><comment>Epub 2011/07/26</comment><pub-id pub-id-type="pmid">21784976</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><etal/></person-group><article-title>Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection</article-title><source>Immunity</source><year>2011</year><volume>35</volume><issue>6</issue><fpage>1023</fpage><lpage>34</lpage><comment>Epub 2011/12/27</comment><pub-id pub-id-type="pmid">22195750</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>SD</given-names></name><name><surname>Wilson</surname><given-names>MS</given-names></name><name><surname>Cheever</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><issue>7</issue><fpage>3326</fpage><lpage>30</lpage><comment>Epub 2010/03/05</comment><pub-id pub-id-type="pmid">20200276</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhong</surname><given-names>B</given-names></name><name><surname>Blonska</surname><given-names>M</given-names></name><name><surname>Gorjestani</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><etal/></person-group><article-title>USP18 inhibits NF-kappaB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex</article-title><source>The Journal of experimental medicine</source><year>2013</year><comment>Epub 2013/07/05</comment></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>CS</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>NN</given-names></name><name><surname>Kabat</surname><given-names>J</given-names></name><name><surname>Abu-Asab</surname><given-names>M</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction</article-title><source>Nature immunology</source><year>2012</year><volume>13</volume><issue>3</issue><fpage>255</fpage><lpage>63</lpage><comment>Epub 2012/01/31</comment><pub-id pub-id-type="pmid">22286270</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>EF</given-names></name><name><surname>Dekonenko</surname><given-names>A</given-names></name><name><surname>Arko-Mensah</surname><given-names>J</given-names></name><name><surname>Mandell</surname><given-names>MA</given-names></name><name><surname>Dupont</surname><given-names>N</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2012</year><volume>109</volume><issue>46</issue><fpage>E3168</fpage><lpage>76</lpage><comment>Epub 2012/10/25</comment><pub-id pub-id-type="pmid">23093667</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradfute</surname><given-names>SB</given-names></name><name><surname>Castillo</surname><given-names>EF</given-names></name><name><surname>Arko-Mensah</surname><given-names>J</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Mandell</surname><given-names>M</given-names></name><etal/></person-group><article-title>Autophagy as an immune effector against tuberculosis</article-title><source>Current opinion in microbiology</source><year>2013</year><comment>Epub 2013/06/25</comment></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tattoli</surname><given-names>I</given-names></name><name><surname>Sorbara</surname><given-names>MT</given-names></name><name><surname>Vuckovic</surname><given-names>D</given-names></name><name><surname>Ling</surname><given-names>A</given-names></name><name><surname>Soares</surname><given-names>F</given-names></name><name><surname>Carneiro</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Amino acid starvation induced by invasive bacterial pathogens triggers an innate host defense program</article-title><source>Cell host &#x00026; microbe</source><year>2012</year><volume>11</volume><issue>6</issue><fpage>563</fpage><lpage>75</lpage><comment>Epub 2012/06/19</comment><pub-id pub-id-type="pmid">22704617</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesquita</surname><given-names>FS</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Sachse</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>AJ</given-names></name><name><surname>Figueira</surname><given-names>R</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group><article-title>The Salmonella deubiquitinase SseL inhibits selective autophagy of cytosolic aggregates</article-title><source>PLoS pathogens</source><year>2012</year><volume>8</volume><issue>6</issue><fpage>e1002743</fpage><comment>Epub 2012/06/22</comment><pub-id pub-id-type="pmid">22719249</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>N</given-names></name><name><surname>Henry</surname><given-names>T</given-names></name><name><surname>de Chastellier</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Guilhon</surname><given-names>AA</given-names></name><name><surname>Gorvel</surname><given-names>JP</given-names></name><etal/></person-group><article-title>The virulence protein SopD2 regulates membrane dynamics of Salmonella-containing vacuoles</article-title><source>PLoS pathogens</source><year>2010</year><volume>6</volume><issue>7</issue><fpage>e1001002</fpage><comment>Epub 2010/07/29</comment><pub-id pub-id-type="pmid">20664790</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Yoshimori</surname><given-names>T</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name></person-group><article-title>Methods in mammalian autophagy research</article-title><source>Cell</source><year>2010</year><volume>140</volume><issue>3</issue><fpage>313</fpage><lpage>26</lpage><comment>Epub 2010/02/11</comment><pub-id pub-id-type="pmid">20144757</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><issue>7309</issue><fpage>973</fpage><lpage>7</lpage><comment>Epub 2010/08/21</comment><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Barczak</surname><given-names>AK</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title><source>Journal of interferon &#x00026; cytokine research : the official journal of the International Society for Interferon and Cytokine Research</source><year>2005</year><volume>25</volume><issue>11</issue><fpage>694</fpage><lpage>701</lpage><comment>Epub 2005/12/02</comment></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>RM</given-names></name><name><surname>Graeber</surname><given-names>TG</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Montoya</surname><given-names>D</given-names></name><name><surname>Schenk</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title><source>Science</source><year>2013</year><volume>339</volume><issue>6126</issue><fpage>1448</fpage><lpage>53</lpage><comment>Epub 2013/03/02</comment><pub-id pub-id-type="pmid">23449998</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkart</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>JB</given-names></name><name><surname>Zhang</surname><given-names>DE</given-names></name></person-group><article-title>Two independent mechanisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus</article-title><source>The Journal of biological chemistry</source><year>2012</year><volume>287</volume><issue>7</issue><fpage>4883</fpage><lpage>93</lpage><comment>Epub 2011/12/16</comment><pub-id pub-id-type="pmid">22170061</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KI</given-names></name><name><surname>Giannakopoulos</surname><given-names>NV</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name><name><surname>Zhang</surname><given-names>DE</given-names></name></person-group><article-title>Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation</article-title><source>Molecular and cellular biology</source><year>2004</year><volume>24</volume><issue>21</issue><fpage>9592</fpage><lpage>600</lpage><comment>Epub 2004/10/16</comment><pub-id pub-id-type="pmid">15485925</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Genetic background affects the allelic expression of 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> and D2.Cg-<italic>Usp18<sup>Ity9</sup></italic></title><p>Mice were infected intravenously with 1.5 X 10<sup>4</sup> CFUs <italic>Salmonella</italic> Typhimurium isolate Keller and (A) survival was monitored for 24 days (129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic>, left panel; Log-rank (Mantel-Cox) p &#x0003c;0.001) or 14 days (D2.Cg-<italic>Usp18<sup>Ity9</sup></italic>, right panel; Log-rank (Mantel-Cox) p &#x0003c;0.007); <italic>Usp18<sup>+/+</sup></italic> (n=4), <italic>Usp18<sup>Ity9</sup></italic> (n=7), (B) bacterial load was measured in the spleen and liver at 8 days post-infection (p.i.) (129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic>, left panel; *** p &#x0003c; 0.0001) or 5 days p.i. (D2.Cg-<italic>Usp18<sup>Ity9</sup></italic>, right panel; ** p = 0.0015 and *** p = 0.0002) (<italic>Usp18<sup>+/+</sup></italic>, dark circles and <italic>Usp18<sup>Ity9</sup></italic>, open circles), and (C&#x02013;D) cytokines were measured at 8 days p.i. (129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic>, left panel) or 5 days p.i. (D2.Cg-<italic>Usp18<sup>Ity9</sup></italic>, right panel) in the serum by ELISA in <italic>Usp18<sup>+/+</sup></italic> (black, n=5), <italic>Usp18<sup>Ity9</sup></italic> (white, n=5); * p = 0.01.</p></caption><graphic xlink:href="nihms4329f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>The susceptibility of 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice to <italic>Salmonella</italic> infection is not due to increase ISG15 expression and function</title><p>(A&#x02013;B) <italic>Usp18<sup>+/+</sup></italic> (black, n=3) and 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> (white, n=3) mice were infected intravenously with 10<sup>3</sup> CFUs <italic>Salmonella</italic> Typhimurium for 8 days and (A) RNA was extracted from spleen for qRT-PCR (*p = 0.017, **p = 0.0035) and (B) ISG15 was measured in the serum by ELISA (*** p &#x0003c; 0.0001) (C) Western blot analysis of bone marrow derived macrophages stimulated with LPS for 18 h. (D) HEK293T cells were transfected as indicated and immunoblotting was performed. Total protein staining with Ponceau S was used to confirm equal loading. (E) Survival of mice infected with <italic>Salmonella</italic> Typhimurium for 14 days; <italic>Usp18<sup>Ity9</sup>Isg15<sup>+/+</sup></italic> (n=8), <italic>Usp18<sup>Ity9</sup>Isg15<sup>+/&#x02212;</sup></italic>(n=12), <italic>Usp18<sup>Ity9</sup>Isg15<sup>&#x02212;/&#x02212;</sup></italic> (n=10), <italic>Usp18<sup>+/+</sup>Isg15<sup>+/+</sup></italic> (n=8), <italic>Usp18<sup>+/+</sup>Isg15<sup>+/&#x02212;</sup></italic> (n=8), <italic>Usp18<sup>+/+</sup>Isg15<sup>&#x02212;/&#x02212;</sup></italic> (n=7); Log-rank (Mantel-Cox) p &#x0003c;0.0001 and (E&#x02013;F) bacterial load in the spleen and liver was measured at (F) 4 days p.i. in <italic>Usp18<sup>Ity9</sup></italic> mice (left panel, <italic>Usp18<sup>Ity9</sup>Isg15<sup>+/+</sup></italic>, dark circles and <italic>Usp18<sup>Ity9</sup>Isg15<sup>&#x02212;/&#x02212;</sup></italic>) and (G) 8 days p.i. in <italic>Usp18<sup>+/+</sup></italic> (right panel, <italic>Usp18<sup>+/+</sup>Isg15<sup>+/+</sup></italic>, dark circles and <italic>Usp18<sup>Ity9</sup>Isg15<sup>&#x02212;/&#x02212;</sup></italic>, open circles).</p></caption><graphic xlink:href="nihms4329f2"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Blocking type I IFN signaling partially rescues the susceptibility of 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> mice to <italic>Salmonella</italic> infection</title><p>(A&#x02013;B) <italic>Usp18<sup>+/+</sup></italic> (black, n=3) and 129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> (white, n=3) mice were infected intravenously with 1.5 X 10<sup>4</sup> CFUs <italic>Salmonella</italic> Typhimurium for 8 days and (A) RNA was extracted from spleen for qRT-PCR (*p = 0.015) (B) Western blot analysis was performed on spleen tissue lysates; n=3 mice/genotype (C) Hela cells were transduced with retrovirus for expressing the wild type and mutant USP18 as indicated, stimulated with IFN&#x003b1; (3000 U/mL, 15 min) and immunoblotting was performed. Total protein staining with Ponceau S was used to confirm equal loading. (D&#x02013;E) <italic>Usp18<sup>Ity9</sup></italic> mice were given MAR1-5A3 or isotype control 1 day prior to infection with <italic>Salmonella</italic> Typhimurium and (D) survival was monitored for 22 days p.i.; n=5 mice/treatment; Log-rank (Mantel-Cox) p &#x0003c;0.005 and (E) bacterial load was measured in the spleen and liver in at 8 days p.i. (IgG, dark circles and MAR1-5A3, open circles; **p = 0.001 and 0.005 for spleen and liver, respectively).</p></caption><graphic xlink:href="nihms4329f3"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> have increased IL-10 and deregulated expression of autophagy markers</title><p>Mice were infected intravenously with <italic>Salmonella</italic> Typhimurium for 8 days and (A) RNA was extracted from spleen for qRT-PCR; (**p = 0.001), (B) IL-10 was measured in the serum by ELISA (*p = 0.019), and (C&#x02013;F) Western blot analysis was performed on spleen tissue lysates using antibodies for STAT3 or p-STAT3 (C), p62 (D), OPTN (E) and LC3 (F). (G&#x02013;H) RNA was extracted from spleen for qRT-PCR (*p = 0.05); (I) BMDM were infected with heat-killed <italic>Salmonella</italic> (MOI = 50), stained with CM-H<sub>2</sub>DCFDA and analyzed by FACS. Data is represented as mean fluorescence intensity fold changes (*p = 0.01); (J) IL-10 was measured in the serum of MAR1-5A3 or IgG control treated mice at 8 days p.i. by ELISA (***p = 0.0005); (K) Western blot analysis of OPTN was performed on spleen tissue lysates from MAR1-5A3 or IgG control treated mice at 8 days p.i. &#x003b2;-actin was used as a loading control.</p></caption><graphic xlink:href="nihms4329f4"/></fig><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><title>129S1.Cg-<italic>Usp18<sup>Ity9</sup></italic> have increased IL-1&#x003b2; and an elevated Th17 response</title><p>Mice were infected intravenously with 1.5 X 10<sup>4</sup> CFUs <italic>Salmonella</italic> Typhimurium for 8 days and (A) RNA was extracted from spleen for qRT-PCR (** p = 0.009), (B) Western blot analysis was performed on spleen tissue lysate using an antibody for IL-1&#x003b2;, (C) Splenocytes were harvested and cultured for 24 h prior to measuring IL-1&#x003b2; in the supernatant by ELISA, (D&#x02013;E) RNA was extracted from spleen for qRT-PCR of (D) IL-23 (*p = 0.02, **p = 0.006) and (E) IL-17 (**p = 0.001), (F) Flow cytometry of intracellular IL-17 in CD4<sup>+</sup> T cells from the spleen (*p = 0.016). n=3&#x02013;5 mice/genotype from 2 experiments.</p></caption><graphic xlink:href="nihms4329f5"/></fig><fig id="F6" orientation="portrait" position="float"><label>Figure 6</label><caption><title><italic>Usp18<sup>Ity9</sup></italic>are more susceptible to <italic>M. tuberculosis</italic> infection</title><p>Mice were infected by aerosol with 100 CFUs of H37Rv and (A) survival was monitored for 150 days p.i. (p &#x0003c; 0.001), n=11 mice/genotype from 2 experiments (B) bacterial load was measured in the lung and spleen (<italic>Usp18<sup>+/+</sup></italic>, dark circles and <italic>Usp18<sup>Ity9</sup></italic>, open circles) at 42 days p.i. (***p = 0.005 and 0.001 for lung and spleen, respectively), (C) cytokines were measured in the serum by ELISA at day 42 p.i. n=6&#x02013;8 mice/genotype and (D) RNA was extracted from lung for qRT-PCR n=3 mice/genotype (*p = 0.05, **p = 0.002).</p></caption><graphic xlink:href="nihms4329f6"/></fig></floats-group></article>